Advertisement
Mayo Clinic Proceedings Home

Transmyocardial and Percutaneous Myocardial Revascularization: Current and Future Role in the Treatment of Coronary Artery Disease

      Transmyocardial revascularization (TMR) is a new treatment modality under evaluation in patients with severely symptomatic, diffuse coronary artery disease, in whom the potential for medical or interventional management has been exhausted. Preliminary clinical trials show improved ischemic symptoms within the first 3 months in about 70% of TMR-treated patients. The original proposed mechanism of surgical or catheter-based TMR (percutaneous myocardial revascularization [PMR]) was that channels mediate direct blood flow between the left ventricular cavity and ischemic myocardium. However, several alternative explanations for the clinical success of TMR have recently been suggested, including improved perfusion by angiogenesis, an anesthetic effect by nerve destruction, and a potential placebo effect. This article reviews the clinical role of TMR/PMR, its possible pathophysiologic mechanisms, and its controversies. It provides an overview of the actual scientific and clinical status of TMR and details future directions.
      CABG (coronary artery bypass grafting), CCS (Canadian Cardiovascular Society), PMR (percutaneous myocardial revascularization), TMR (transmyocardial revascularization)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mirhoseini M
        • Cayton MM
        Revascularization of the heart by laser.
        J Microsurg. 1981; 2: 253-260
        • Mirhoseini M
        • Shelgikar S
        • Cayton M
        Clinical and histological evaluation of laser myocardial revascularization.
        J Clin Laser Med Surg. 1990; 8: 73-77
        • Frazier OH
        • Kadipasaoglu KA
        • Cooley DA
        Transmyocardial laser revascularization: does it have a role in the treatment of ischemic heart disease?.
        Tex Heart inst J. 1998; 25: 24-29
        • Burkhoff D
        • Fulton R
        • Whartott K
        • et al.
        Myocardial perfusion through naturally occurring subendocardia] channels.
        J Tkorac Cardiovasc Surg. 1997; 114: 497-499
        • Sen PK
        • Udwadia TE
        • Kinare SG
        • Parulkar GB
        Transmyocardial acupuncture.
        J Thorac Cardiovasc Surg. 1965; 50: 181-189
        • Horvath KA
        • Mannling F
        • Cummings N
        • et al.
        Transmyocardial laser revascularization.
        J Thorac Cardiovasc Surg. 1996; 111: 1047-1053
        • Horvath KA
        • Cohn LH
        • Cooley DA
        • et al.
        Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease.
        J Thorac Cardiovasc Surg. 1997; 113: 645-653
        • Kohmoto T
        • Argenziano M
        • Yamamoto N
        • et al.
        Assessment of transmyocardial perfusion in alligator hearts.
        Circulation. 1997; 95: 1585-1591
        • Whittaker P
        • Kloner RA
        Transmural channels as a source of blood flow to ischemic myocardium? insights from the reptilian heart Icditorial).
        Circulation. 1997; 95: 1357-1359
        • Weam JT
        • Mettier SR
        • Klumpp TG
        • Zschiesche LJ
        The nature of vascular communications between coronary arteries and chambers ofheaft.
        Am Heart J. 1933; 9: 143-164
        • Tsang JC
        • Chiu RC
        The phantom of “myocardial sinusoids”: a historical reappraisal.
        Ann Thorac Surg. 1995; 60: 1831-1835
        • Goldman A
        • Greenstone SM
        • Preuss FS
        • et al.
        Experimental methods for producing a collateral circulation to heart directly from left ventricle.
        JThoracSurg. 1956; 31: 364-374
        • Beck CS
        Development of new blood supply to heart by operation.
        AnnSurg. 1935; 102: 801-813
        • Walter P
        • Hundeshagen H
        • Borst HG
        Treatment of acute myocardial infarction by transmural blood supply from the ventricular cavity.
        Eur Surg Res. 1971; 3: 130-138
        • Khazei AH
        • Kime WP
        • Papadopoulos C
        • Cowley RA
        Myocardial canalization.
        Ann Thorac Surg. 1968; 6: 163-171
        • Massimo C
        • Boffi L
        Myocardial revascularization by a new method of carrying blood directly from the left ventricular cavity into the coronary circulation.
        J Thorac Surg. 1957; 34: 257-264
        • Vineberg AM
        Development of anastomosis between coronary vessels and transplanted inlemal mammary artery.
        Can Med Assoc J. 1946; 55: 117-119
        • Effler DB
        Myocardial revascularization; a 14-year overview of the Cleveland Clinic experience.
        JAMA. 1976; 235: 828-832
        • Gorlin R
        • Taylor WJ
        Selective revascularization of the myocardium by intcrnal-mammary-artery implant.
        N Engl J Med. 1966; 275: 283-290
        • White M
        • Hcrshey JE
        Multiple transmyocardial puncture revascularization in refractory ventricular fibrillation due to myocardial ischemia.
        Ann Thorac Surg. 1968; 6: 557-563
        • Hershey JE
        • While M
        Transmyocardial puncture revascularization: a possible emergency adjunct to arterial implant surgery.
        Geriatrics. 1969; 24: 101-108
        • Frazier OH
        • Kadipasaoglu K
        Transmyocardial laser revascularization.
        Curr Opin Cardiol. 1996; 11: 564-567
        • Oesterle SN
        • Reifart NJ
        • Meier B
        • et al.
        Initial results of laser-based percutaneous myocardial revascularization for angina pectoris.
        Am J Cardiol. 1998; 82: 659-662
        • Iskandrian AE
        • Sink JD
        • VanDecker W
        Images in cardiovascular medicine: improvement of myocardial perfusion after transmyocardial laser revascularization and coronary artery bypass graft surgery.
        Circulation. 1998; 98: 728-729
        • March RJ
        Transmyocardial laser revascularization with the C02 laser.
        Semin Thorac Cardiovasc Surg. 1999; 11: 12-18
        • Vincent JG
        • Bardos P
        • Kruse J
        • Maass D
        End stage coronary disease treated with the transmyocardial C03 laser revascularization.
        Eur J Cardiothorac Surg. 1997; 11: 888-894
        • Allen KB
        • Fudge TL
        • Schoettle Jr, P
        • et al.
        Prospective randomized multicenter trial of transmyocardial revascularization versus maximal medical management in patients with refractory class IV angina: 12-month results [abstract].
        Circulation. 1998; 98: I-476
        • Schofield PM
        • Sharpies LD
        • Caine N
        • et al.
        Transmyocardial laser revascularization in patients with refractory angina: a randomised controlled trial.
        Lancet. 1999; 353: 519-524
        • Komowski R
        • Hong MK
        • Leon MB
        Current perspectives on direct myocardial revascularization.
        Am J Cardiol. 1998; 81: 44E-48E
        • Allen KB
        • Delrossi AJ
        • Realyvasquez F
        • et al.
        Transmyocardial revascularization combined with coronary artery bypass grafting versus coronary artery bypass grafting alone [abstract].
        Circulation. 1998; 98: I-217
        • deGuzman BJ
        • Lautz DB
        • Chen FY
        • et al.
        Thoracoscopic transmyocardial laser revascularization.
        Ann Thorac Surg. 1997; 64: 171-174
        • Yano OJ
        • Bielefeld MR
        • Jeevanandam V
        • et al.
        Prevention of acute regional ischemia with endocardial laser channels.
        Ann Thorac Surg. 1993; 56: 46-53
        • Kim CB
        • Kesten R
        • Javier M
        • et al.
        Percutaneous method of laser transmyocardial revascularization.
        Cathet Cardiovasc Diagn. 1997; 40: 223-228
        • McKenna CJ
        • Ellis L
        • Kwon HM
        • et al.
        Identical histologic results of transmyocardial revascularization by epicardial C02 laser and endocardial radiofrequency energy [abstract].
        Circulation. 1997; 96: I-2l7
        • McKenna CJ
        • Kwon HM
        • Sangiorgi G
        • et al.
        Microscopic 3D-CT imaging after catheter-based channel creation in normal porcine myocardium and histologic comparison with ischemic human myocardium previously treated with surgical transmyocardial revascularization [abstract].
        J Am Coll Cardiol. 1998; 31: 164A
        • Kantor B
        • McKenna C
        • Ritman E
        • et al.
        Does channel depth affect chronic outcome after catheter-based myocardial revascularization?.
        JAm Coll Cardiol. 1999; 33: 333A
        • von Knobelsdorff G
        • Brauer P
        • Tonner PH
        • et al.
        Transmyocardial laser revascularization induces cerebral micrnembolizalion.
        Anes-thesiology. 1997; 87: 58-62
        • Cooley DA
        • Frazier OH
        • Kadipasaoglu KA
        • et al.
        Transmyocardial laser revascularization: clinical experience with twelve-month follow-up.
        J Thorac Cardiovasc Surg. 1996; 111: 791-797
        • Patel VS
        • Radovancevic B
        • Springer W
        • et al.
        Revascularization procedures m patients with transplant coronary artery disease.
        Eur J Cardiothorac Surg. 1997; 11: 895-901
        • Trehan N
        • Mishra M
        • Bapna R
        • et al.
        Transmyocardial laser revascularisation combined with coronary artery bypass grafting without cardiopulmonary bypass.
        Eur J Cardiothorac Surg. 1997; 12: 276-284
        • Gassier N
        • Wintzer HO
        • Stubbe HM
        • et al.
        Transmyocardial laser revascularization: histological features in human nonresponder myocardium.
        Circulation. 1997; 95: 371-375
        • Gassier N
        • Stubbe HM
        Clinical data and histological features of transmyocardial revascularization with C02-laser.
        Eur J Cardiothorac Surg. 1997; 12: 25-30
        • Hardy RI
        • Bove KE
        • James FW
        • et al.
        A histologic study of laser-induced transmyocardial channels.
        Lasers Surg Med. 1987; 6: 563-573
        • Krabatsch T
        • Schaper F
        • Tambeur L
        • et al.
        Histomorphology after transmyocardial laser revascularization [in German |.
        Herz. 1997; 22: 205-210
        • Krabaisch T
        • Schaper F
        • Leder C
        • et al.
        Histological findings after transmyocardial laser revascularization.
        J Card Surg. 1996; 11: 326-331
        • Fisher PE
        • Kohmoto T
        • DeRosa CM
        • et al.
        Histologic analysis of transmyocardial laser channels: comparison of C02 and hoi mi urn: YAG lasers.
        Ann Thorac Surg. 1997; 64: 466-472
        • Horvath KA
        • Smith WJ
        • Laurence RG
        • et al.
        Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization.
        J Am Coll Cardiol. 1995; 25: 258-263
        • Cooley DA
        • Frazier OH
        • Kadipasaoglu KA
        • et al.
        Transmyocardial laser revascularization: anatomic evidence of long-term channel patency.
        Tex Heart InstJ. 1994; 21: 220-224
        • Yamamoto N
        • Kohmoto T
        • Gu A
        • et al.
        Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revas-cularizalion.
        J Am Cotl Cardiol. 1998; 31: 1426-1433
        • Kohmoto T
        • Fisher PE
        • Gu A
        • et al.
        Does blood flow through holm ium: YAG transmyocardial laser channels?.
        Ann Thorac Surg. 1996; 61: 861-868
        • Hardy RJ
        • James FW
        • Millard RW
        • Kaplan S
        Regional myocardial blood flow and cardiac mechanics in dog hearts with CO, laser-induced intramyocardial revascularization.
        Basic Res Cardiol. 1990; 85: 179-197
        • Beck Jr, L
        • D'Amore PA
        Vascular development: cellular and molecular regulation.
        FASEBJ. 1997; 11: 365-373
        • Folkman J
        Angiogenesis.
        Ann NYAcadSci. 1982; 401: 212-227
        • Folkman J
        • Klagsbum M
        Angiogenic factors.
        Science. 1987; 235: 442-447
        • Folkman J
        Angiogenesis in cancer, vascular, rheumatoid and other disease.
        Nat Med. 1995; 1: 27-31
        • Weihrauch D
        • Arras M
        • Zimmermann R
        • Schaper J
        Importance of monocytes/macrophages and fibroblasts for healing of microne-croses in porcine myocardium.
        Mol Cell Biochem. 1995; 147: 13-19
        • Folkman J
        Clinical applications of research on angiogenesis.
        N Engl J Med. 1995; 333: 1757-1763
        • Ware JA
        • Simons M
        Angiogenesis in ischemic heart disease.
        Nat Med. 1997; 3: 158-164
        • Schaper W
        • Ito WD
        Molecular mechanisms of coronary collateral vessel growth.
        Circ Res. 1996; 79: 911-919
        • Mack CA
        • Magovem CJ
        • Hahn RT
        • et al.
        Channel patency and neovascularization after transmyocardial revascularization using an excimer laser.
        Circulation. 1997; 96: II-65-II-69
        • Sasayama S
        • Fujita M
        Recent insights into coronary collateral circulation.
        Circulation. 1992; 85: 1197-1204
        • Nathan CF
        Secretory products of macrophages.
        J Clin invest. 1987; 79: 319-326
        • Schunke M
        • Kruss C
        • Mecke H
        • Werner JA
        Characteristic features of wound healing in laser-induced incisions.
        Adv Otorhino-laryngol. 1995; 49: 8-14
        • Nath S
        • Haines DE
        Biophysics and pathology of catheter energy delivery systems.
        Prog Cardiovasc Dis. 1995; 37: 185-204
        • Weber HP
        • Heinze A
        • Enders S
        • et al.
        Laser versus radiofrequency catheter ablation of ventricular myocardium in dogs; a comparative test.
        Cardiology. 1997; 88: 346-352
        • Milano A
        • Pratali S
        • Tanarini G
        • et al.
        Early results of transmyocardial revascularization with a holmium laser.
        Ann Thorac Surg. 1998; 65: 700-704
        • Waltenberger J
        Modulation of growth factor action: implications for the treatment of cardiovascular diseases.
        Circulation. 1997; 96: 4083-4094
        • Schaper W
        Angiogenesis in the adult heart.
        Basic Res Cardiol. 1991; 86: 51-56
        • Malekan R
        • Reynolds C
        • Namla N
        • et al.
        Angiogenesis in transmyocardial laser revascularization.
        Circulation. 1998; 98: II-62-11-65
        • Unger EF
        • Sheffield CD
        • Epsiein SE
        Creation of anastomoses between an extracardiac artery and the coronary circulation: proof that myocardial angiogenesis occurs and can provide nutritional blood flow to the myocardium.
        Circulation. 1990; 82: 1449-1466
        • Kwong KF
        • Kanellopoulos GK
        • Nickols JC
        • et al.
        Transmyocardial laser treatment denervatcs canine myocardium.
        J Thorac Cardiovase Surg. 1997; 114: 883-889
        • Cobb LA
        • Thomas GI
        • Dillard DH
        • et al.
        An evaluation of intemal-mammary-anery ligation by a double-blind technic.
        N Engl J Med. 1959; 260: 1115-1118
        • Benson H
        • McCallie Jr, DP
        Angina pectoris and the placebo effect.
        N Engl J Med. 1979; 300: 1424-1429
        • Dimond EG
        • Kittle CF
        • Crockett JE
        Comparison of internal mammary artery ligation and sham operation for angina pectoris.
        Am J Cardiol. 1960; 5: 483-486
        • Schoebel FC
        • Frazier OH
        • Jessurun GA
        • et al.
        Refractory angina pectoris in end-stage coronary artery disease: evolving therapeutic concepts.
        Am Heart J. 1997; 134: 587-602
        • Horvath KA
        • Cohn LH
        • Cooley DA
        • et al.
        Functional improvement, long term survival and angina relief after transmyocardial revascularization with a CO, laser [abstract].
        Circulation. 1999; 98: I-217
        • Giordano FJ
        • Ping P
        • McKiman D
        • et al.
        IntTacoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart.
        Nat Med. 1996; 5: 534-539
        • Fleischer KJ
        • Goldschmidt-Clermont PJ
        • Fonger JD
        • et al.
        One-month histologic response of transmyocardial laser channels with molecular intervention.
        Ann Thorac Surg. 1996; 62: 1051-1058
        • Yamamoto N
        • Kohmoto T
        • Gu A
        • et al.
        Basic fibroblast growth factor enhances ihe angiogenic effects of transmyocardial laser revascularization |abstract].
        Circulation. 1998; 98: I-217